Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001073369 | SCV001238910 | uncertain significance | Retinal dystrophy | 2019-01-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002482150 | SCV002780435 | uncertain significance | Joubert syndrome 7; Meckel syndrome, type 5; COACH syndrome 3 | 2021-11-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002554657 | SCV003280806 | uncertain significance | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2022-08-08 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 204 of the RPGRIP1L protein (p.Ala204Asp). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with RPGRIP1L-related conditions. ClinVar contains an entry for this variant (Variation ID: 865839). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |